FORT LAUDERDALE, Fla., April 12 (Bernama-GLOBE NEWSWIRE) — Rundo International Pharmaceutical Research & Development Co., Ltd. (Rundo), a prominent, Shanghai-headquartered contract research organization (CRO) has selected eClinical solutions from OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the terms of two separate agreements, Rundo will use OmniComm’s TrialMaster EDC and TrialOne for research.
Rundo’s customers in China include domestic and multinational companies, with research ranging from Phase I through IV clinical trials. After comprehensive evaluations, Rundo selected OmniComm’s eClinical solutions for multiple reasons, including the availability of mature and validated systems, multiple therapeutic areas of experience, support of industry standards and competitive pricing. Additionally, OmniComm’s eClinical solutions provide market-leading technology for early phase research and Phase II-IV studies.